encepp

Study about the results of the addition of a sulfonylurea, DPP4 inhibitors or SGLT2 inhibitors as a second antidiabetic drug in patients with diabetes mellitus type 2 in treatment with metformin and insufficient glycemic control. (eControl Met +)

05/05/2018
14/03/2024
EU PAS number:
EUPAS23769
Study
Planned

ENCePP Code of conduct

No
Data sources

Data source(s)

Data sources (types)

Drug dispensing/prescription data
Electronic healthcare records (EHR)
Use of a Common Data Model (CDM)

CDM mapping

No
Data quality specifications

Check conformance

Unknown

Check completeness

Unknown

Check stability

Unknown

Check logical consistency

Unknown
Data characterisation

Data characterisation conducted

No